Perceived infection | Perceived severity | Autonomous motivation | Adherence | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fixed effects | F-value | p-value | η2p | F-value | p-value | η2p | F-value | p-value | η2p | F-value | p-value | η2p | |||||||
Between-subject predictors | |||||||||||||||||||
Age | 760.38 | <.001*** | .01 | 3536.33 | <.001*** | .04 | 2723.83 | <.001*** | .04 | 2113.59 | <.001*** | .03 | |||||||
Gender | 736.18 | <.001*** | .01 | 2147.62 | <.001*** | .02 | 1624.76 | <.001*** | .02 | 3142.29 | <.001*** | .04 | |||||||
Comorbity | 247.74 | <.001*** | .00 | 2398.83 | <.001*** | .02 | 457.23 | <.001*** | .00 | 303.89 | <.001*** | .00 | |||||||
Education level | 111.76 | <.001*** | .00 | 149.16 | <.001*** | .00 | 17.05 | <.001*** | .00 | 29.91 | <.001*** | .01 | |||||||
Vaccination status | 2868.68 | <.001*** | .15 | 4935.84 | <.001*** | .10 | 6115.60 | <.001*** | .14 | 1631.67 | <.001*** | .13 | |||||||
Between-days predictors | |||||||||||||||||||
Phases | 23.24 | <.001*** | .03 | 437.53 | <.001*** | .05 | 129.54 | <.001*** | .04 | 93.06 | <.001*** | .02 | |||||||
Cross-level interaction | |||||||||||||||||||
Phases : Vaccination status | 526.01 | <.001*** | .04 | 536.83 | <.001*** | .06 | 575.03 | <.001*** | .05 | 88.41 | <.001*** | .03 | |||||||
Random effects: | |||||||||||||||||||
Number of days | 0.22 | 0.14 | 0.22 | 0.14 | |||||||||||||||
Residual | 0.81 | 0.78 | 1.11 | 0.99 | |||||||||||||||
Max VIF | 3.05 | 3.07 | 2.94 | 3.02 | |||||||||||||||
R2 (marginal/conditional) | .09/.15 | .26/.27 | .19/.22 | .11/.13 |